1-4 of 4
Ying-Wei Lin
Close
Sort by
Journal Articles

A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma

Ying-Wei Lin, Zanna M. Beharry, Elizabeth G. Hill, Jin H. Song, Wenxue Wang, Zuping Xia, Zhenhua Zhang, Peter D. Aplan, Jon C. Aster, Charles D. Smith, Andrew S. Kraft
Journal: Blood
Blood (2010) 115 (4): 824–833.
https://doi.org/10.1182/blood-2009-07-233445
Published: 2010
Includes: Supplemental data
Journal Articles

STAT3: A Direct HMGA1 Gene Target Important in Lymphoid Malignancy.

Linda Resar, MD, Surajit Dhara, Ph.D., Takita Felder Sumter, Ph.D., Mita Mukherjee, Ph.D., James Turkson, Ph.D., Rich Jove, Ph.D., Ossama Elbahloul, M.D., Peter Aplan, M.D., Ying-Wei Lin, M.D., Ph.D., Raka Bhattacharya, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2222.
https://doi.org/10.1182/blood.V108.11.2222.2222
Published: 2006
Journal Articles

Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma

Ying-Wei Lin, Rebecca A. Nichols, John J. Letterio, Peter D. Aplan
Journal: Blood
Blood (2006) 107 (6): 2540–2543.
https://doi.org/10.1182/blood-2005-07-3013
Published: 2006
Includes: Supplemental data
Journal Articles

NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia

Ying-Wei Lin, Christopher Slape, Zhenhua Zhang, Peter D. Aplan
Journal: Blood
Blood (2005) 106 (1): 287–295.
https://doi.org/10.1182/blood-2004-12-4794
Published: 2005
Includes: Supplemental data